Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,563,439
+$466,637 QoQ
Shares Held
6,156
+37.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#2,566
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verum Partners LLC holds $8,397,946 across 6 Drug Manufacturers - General names. JNJ ranks #2 (18.6% of the industry book) .
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,563,439 | 6,156 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,096,802 | 4,487 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $653,962 | 3,160 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $651,936 | 3,516 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $548,983 | 3,594 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $505,812 | 3,050 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $538,564 | 3,724 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $634,626 | 3,916 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $528,368 | 3,615 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $573,122 | 3,623 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $640,596 | 4,087 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $707,416 | 4,542 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $591,568 | 3,574 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $423,460 | 2,732 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $531,539 | 3,009 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||